Dr Martens reports steady trading
Footwear brand Dr Martens said trading since the start of its current financial year has been in line with expectations, ahead of its annual general meeting.
Direct-to-consumer (DTC) sales in the Americas, particularly full-price retail, continued to perform well.
Growth in the Asia-Pacific region, especially in South Korea, also supported overall results. These helped offset softer trading in Europe, where the UK market remains challenging.
Autumn/Winter order books were described as healthy, with year-on-year increases in EMEA and stable volumes in the Americas, which now include a broader product mix.
The company confirmed that guidance for FY26 remains unchanged and said it remains focused on implementing its new “consumer-first” Levers for Growth strategy, which aims to expand market reach, increase purchase occasions, and simplify operations.
Further updates will follow in November.
image - Dr Martens
